SciELO - Scientific Electronic Library Online

 
vol.46 issue2National vaccination campaign for the elimination of rubella and the congenital rubella syndrome, Bolivia 2006Intoxication by star anise in an infant author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista de la Sociedad Boliviana de Pediatría

On-line version ISSN 1024-0675

Abstract

ALVIS GUZMAN, Nelson; DE LA HOZ RESTREPO, Fernando  and  VIVAS CONSUELO, David. The cost-effectiveness of Haemophilus influenzae type b vaccine for children under 2 years of age in Colombia. Rev. bol. ped. [online]. 2007, vol.46, n.2, pp.95-114. ISSN 1024-0675.

Objective. Conjugate vaccines are the best public health tools available for preventing most invasive diseases caused by Haemophilus influenzae type b (Hib), but the high cost of the vaccines has so far kept them from being introduced worldwide. The objective of this study was to estimate the cost-effectiveness of introducing Hib conjugate vaccines for the prevention of meningitis and pneumonia among children under 2 years of age in Colombia. Methods. We estimated the direct and indirect costs of managing in-hospital pneumonia and meningitis cases. In addition, following the recommendations of the World Health Organization, we assessed the cost-effectiveness of Hib vaccination programs. We also estimated the costs for preventing Hib cases, and the cost per year of life saved in two hypothetical situations: (1) with vaccination against Hib (with 90% coverage) and (2 without vaccination). Results. The average in-hospital treatment costs were US$ 611.50 (95% confidence interval (95% CI) = US$ 532.2 to US$ 690.8) per case of pneumonia and US$ 848.9 (95% CI = US$ 716.8 to US$ 981.0) per case of meningitis. The average cost per Hib case prevented was US$ 316.7 (95% CI = US$ 294.2 to US$ 339.2). In terms of cost-effectiveness, the cost would be US$ 2.38 per year of life saved for vaccination, versus US$ 3.81 per year of life saved without vaccination. Conclusion. Having an adequate Hib vaccination program in Colombia could prevent around 25 000 cases of invasive disease per year, representing a cost savings of at least US$ 15 million annually. Furthermore, the program could prevent some 700 deaths per year and save 44 054 years of life per year.

Keywords : Haemophilus influenzae type b; immunization; health resources; cost-benefit analysis; Colombia.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License